Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GRTS | F | Gritstone Oncology, Inc. | 0.00 | |
ARDS | F | Aridis Pharmaceuticals Inc. | 100.00 | |
CVM | F | Cel-Sci Corporation | -0.90 | |
IMCR | F | Immunocore Holdings plc | -3.38 | |
NBTX | F | Nanobiotix S.A. | -4.81 | |
ALPN | F | Alpine Immune Sciences, Inc. | 0.00 | |
THMO | F | ThermoGenesis Holdings, Inc. | 0.00 | |
ADTX | F | ADiTx Therapeutics, Inc. | 0.62 | |
TCBP | F | TC BioPharm (Holdings) plc | -0.75 | |
TSBX | F | Turnstone Biologics Corp. | -0.19 |
Related Industries: Biotechnology Broadcasting - TV Diagnostics & Research Medical Care Medical Devices Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.31 | |
BBP | B | BioShares Biotechnology Products Fund | 1.22 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 1.06 | |
CANC | D | Tema Oncology ETF | 0.67 | |
BMED | D | BlackRock Future Health ETF | 0.54 |
Compare ETFs
- Immunotherapy
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles